249 related articles for article (PubMed ID: 22125636)
1. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro.
Davies JM; Carroll ML; Li H; Poh AM; Kirkegard D; Towers M; Upham JW
PLoS One; 2011; 6(11):e27898. PubMed ID: 22125636
[TBL] [Abstract][Full Text] [Related]
2. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses.
Bochkov YA; Busse WW; Brockman-Schneider RA; Evans MD; Jarjour NN; McCrae C; Miller-Larsson A; Gern JE
Respir Res; 2013 Oct; 14(1):98. PubMed ID: 24219422
[TBL] [Abstract][Full Text] [Related]
3. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Eur Respir J; 2000 Jan; 15(1):68-74. PubMed ID: 10678623
[TBL] [Abstract][Full Text] [Related]
4. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.
Marcellini A; Swieboda D; Guedán A; Farrow SN; Casolari P; Contoli M; Johnston SL; Papi A; Solari R
Eur J Pharmacol; 2021 Feb; 893():173839. PubMed ID: 33359650
[TBL] [Abstract][Full Text] [Related]
6. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.
Skevaki CL; Christodoulou I; Spyridaki IS; Tiniakou I; Georgiou V; Xepapadaki P; Kafetzis DA; Papadopoulos NG
Clin Exp Allergy; 2009 Nov; 39(11):1700-10. PubMed ID: 19549024
[TBL] [Abstract][Full Text] [Related]
7. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
8. Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma.
Rüdiger JJ; Gencay M; Yang JQ; Bihl M; Tamm M; Roth M
Respirology; 2013 Jul; 18(5):840-7. PubMed ID: 23617551
[TBL] [Abstract][Full Text] [Related]
9. Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts.
Todorova L; Gürcan E; Westergren-Thorsson G; Miller-Larsson A
Respir Med; 2009 Nov; 103(11):1755-63. PubMed ID: 19375904
[TBL] [Abstract][Full Text] [Related]
10. Reduced Antiviral Interferon Production in Poorly Controlled Asthma Is Associated With Neutrophilic Inflammation and High-Dose Inhaled Corticosteroids.
Simpson JL; Carroll M; Yang IA; Reynolds PN; Hodge S; James AL; Gibson PG; Upham JW
Chest; 2016 Mar; 149(3):704-13. PubMed ID: 26836898
[TBL] [Abstract][Full Text] [Related]
11. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL; Ma ES; Wen FQ
Acta Pharmacol Sin; 2011 Jan; 32(1):126-32. PubMed ID: 21170080
[TBL] [Abstract][Full Text] [Related]
12. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
Korn SH; Jerre A; Brattsand R
Eur Respir J; 2001 Jun; 17(6):1070-7. PubMed ID: 11491146
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of budesonide alone and in combination with formoterol on IL-5 and RANTES production from mononuclear cells.
Soma T; Takaku Y; Kobayashi T; Hagiwara K; Kanazawa M; Uematsu K; Nagata M
Int Arch Allergy Immunol; 2008; 146 Suppl 1():22-7. PubMed ID: 18504402
[TBL] [Abstract][Full Text] [Related]
14. β2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers.
Niimi K; Ge Q; Moir LM; Ammit AJ; Trian T; Burgess JK; Black JL; Oliver BG
Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(3):L334-42. PubMed ID: 22101762
[TBL] [Abstract][Full Text] [Related]
15. Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol.
Turner Dl; Ferrari N; Ford WR; Kidd EJ; Nevin B; Paquet L; Renzi P; Broadley KJ
Br J Pharmacol; 2012 Oct; 167(3):515-26. PubMed ID: 22563753
[TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.
Heuck C; Heickendorff L; Wolthers OD
Arch Dis Child; 2000 Oct; 83(4):334-9. PubMed ID: 10999872
[TBL] [Abstract][Full Text] [Related]
17. Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts.
Spoelstra FM; Kauffman HF; Hovenga H; Noordhoek JA; de Monchy JG; Postma DS
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1229-34. PubMed ID: 11029322
[TBL] [Abstract][Full Text] [Related]
18. Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.
Albano GD; Di Sano C; Bonanno A; Riccobono L; Gagliardo R; Chanez P; Gjomarkaj M; Montalbano AM; Anzalone G; La Grutta S; Ricciardolo FL; Profita M
PLoS One; 2013; 8(4):e58892. PubMed ID: 23573194
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
20. Symbicort: controlling asthma in adults.
Lalloo U
Respir Med; 2002 Feb; 96 Suppl A():S16-22. PubMed ID: 11858561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
